ODDB.org: Open Drug Database

Swissmedic Registration	57380	Date of registration	24.02.2006
Company name	Bristol-Myers Squibb SA	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	07.16.10.	Revocation Date
Index Therapeuticus (Swissmedic)	07.16.10.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Vidaza 100 mg	Lyophilisat zur Herstellung einer Injektionssuspension	Lyophilisat pour suspension injectable (Azacitidine 100 mg)	L01BC07

2025	©ywesee GmbH